Search research articles
Contact Us
Filters
Showing results (61-70 of 87) with videos related to
Page
of 9
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 7, 2000
The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: an open label study
P Dorfman-Etrog, H Hermesh, L Prilipko, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
August 1, 1992
Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients
H Hermesh, D Aizenberg, A Weizman, et al.
Acta Psychiatrica Scandinavica
|
March 18, 2009
Obsessive-compulsive disorder: a disorder of pessimal (non-functional) motor behavior
R Zor, H Keren, H Hermesh, et al.
Biological Psychiatry
|
January 1, 1994
T-cell subsets in acute psychotic schizophrenic patients
A Achiron, S Noy, E Pras, et al.
The American Journal of Psychiatry
|
July 27, 2000
Heat intolerance in patients with chronic schizophrenia maintained with antipsychotic drugs
H Hermesh, R Shiloh, Y Epstein, et al.
The Israel Journal of Psychiatry and Related Sciences
|
June 17, 2000
Cushing's syndrome presenting as a schizophrenia-like psychotic state
D Hirsch, G Orr, V Kantarovich, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
December 10, 2015
Dynamic occupation assessment of executive function in adolescents with schizophrenia spectrum disorders: An initial report
E Chubarov, E Sommerfeld, H Hermesh, et al.
Schizophrenia Research
|
October 23, 1998
Bone age in adolescents with schizophrenia and obsessive-compulsive disorder
N Katz, D Gothelf, H Hermesh, et al.
Environmental Monitoring and Assessment
|
August 10, 2011
Urban daily life routines and human exposure to environmental discomfort
I Schnell, O Potchter, Y Yaakov, et al.
Acta Psychiatrica Scandinavica
|
February 1, 1990
Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment
B Spivak, A Weizman, L Wolovick, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 87) with videos related to
Sort By:
Page
of 9
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 7, 2000
The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: an open label study
P Dorfman-Etrog, H Hermesh, L Prilipko, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
August 1, 1992
Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients
H Hermesh, D Aizenberg, A Weizman, et al.
Acta Psychiatrica Scandinavica
|
March 18, 2009
Obsessive-compulsive disorder: a disorder of pessimal (non-functional) motor behavior
R Zor, H Keren, H Hermesh, et al.
Biological Psychiatry
|
January 1, 1994
T-cell subsets in acute psychotic schizophrenic patients
A Achiron, S Noy, E Pras, et al.
The American Journal of Psychiatry
|
July 27, 2000
Heat intolerance in patients with chronic schizophrenia maintained with antipsychotic drugs
H Hermesh, R Shiloh, Y Epstein, et al.
The Israel Journal of Psychiatry and Related Sciences
|
June 17, 2000
Cushing's syndrome presenting as a schizophrenia-like psychotic state
D Hirsch, G Orr, V Kantarovich, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
December 10, 2015
Dynamic occupation assessment of executive function in adolescents with schizophrenia spectrum disorders: An initial report
E Chubarov, E Sommerfeld, H Hermesh, et al.
Schizophrenia Research
|
October 23, 1998
Bone age in adolescents with schizophrenia and obsessive-compulsive disorder
N Katz, D Gothelf, H Hermesh, et al.
Environmental Monitoring and Assessment
|
August 10, 2011
Urban daily life routines and human exposure to environmental discomfort
I Schnell, O Potchter, Y Yaakov, et al.
Acta Psychiatrica Scandinavica
|
February 1, 1990
Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment
B Spivak, A Weizman, L Wolovick, et al.
Page
of 9